A pain medication known as Darvocet has been on the market since 1972, when it first received approval from the U.S. Food & Drug Administration. Less than six years later, the medical community acknowledged a link between the drug (a combination of propoxyphene and acetaminophen) and heart trouble. The concerns…
When a patent expires on a medication, drug companies can produce generic versions of the drug to sell to the public. Unfortunately, this can create significant legal complications. In 2011, a court decision established that generic drugmakers cannot make changes to product labels even if the drugmaker is alerted to…
A recent story from wfmynews2.com takes a closer at the problems many total hip replacement patients are facing do to dangerous and defective artificial hips. As millions of Americans are undergoing total hip replacements members of the “hip generation” are having more problems than they did before surgery. DePuy manufactures…
A recent article in The New York Times examines the risks of Pradaxa. Pradaxa, like Xarelto, is among a relatively new class of blood-thinning drugs turning huge profits for the manufacturer. Patients who had been taking Warfarin, the traditionally prescribed medication to aid in the prevention of strokes, needed to…
Payne v. Novartis, an appeal argued before the United States Court of Appeals for the Sixth Circuit, involved a woman and her husband who sued Novartis, a drug manufacturer, for failing to warn her that its drugs could cause serious damage to her jaw. Those two drugs were Aredia and…
According to recent article in the Boston Business Journal, a technological innovation will allow partial and total knee replacement surgeries to be performed by a robotic arm. The company claims that this robotic arm sets them apart form companies such as Stryker, DePuy, and Zimmer. As your Boston knee replacement…
According to a recent article from Australia, at least 30,000 people in the country have been put at serious risks for internal bleeding after taking Pradaxa. Claims are being made that Boehringer Ingelheim, the drugmaker, was more concerned with marketing and making money than patient safety and failed to warn…
Our testosterone replacement therapy attorneys understand that the Low -T craze sweeping the nation may have some serious health consequences in the near future. A recent article from Fox News examines whether testosterone replacement therapy (TRT) is appropriate for the many new patients taking the medication. According to the article,…
While it has been well established that testosterone levels can lead to aggressive behaviors in males, according to a recent article in Medical News Today, there is a specific neural receptor that is affected by the hormone in a way that causes male aggression. Researchers in Canada performed a study…
A recent article in the Washington Post chronicles the columnist’s experiences as he researches and then undergoes total hip replacement surgery at the age of 45. The point is that hip replacement surgery isn’t just for older people anymore. The article details that the number of total and partial hip…